← Leaderboards
Harry De Koning
Erasmus Medical Center
$12,599,089
Attributed
$63,100,430
Total exposure
10
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$63,100,430 · 10
By mechanism
U01$63,100,430 · 10
Top collaborators
- Sylvia Katina Plevritis42 shared
- Sandra J Lee22 shared
- Jeanne Mandelblatt22 shared
- Amy Trentham-Dietz22 shared
- David T Levy20 shared
- Chung Yin Kong16 shared
- Rafael Meza16 shared
- Donald A Berry13 shared
Others in their field
Top investigators on “Policies”
- David R. Weir · University Of Michigan At Ann Arbor$391,103,270
- Christopher McKay · Battelle Memorial Institute$267,829,683
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Everette D Joseph · Howard University$243,972,016
Research focus
PoliciesCessation Of LifeCancer ControlCancer Intervention And Surveillance Modeling NetworkResearch PersonnelComparativeMalignant NeoplasmsBaseTrendIncidenceScreeningFutureProgramsWorking GroupNatural HistoryHealth PolicyAffectAreaCollaborationsCostMortalityRecording Of Previous EventsEffectivenessMalignant Breast Neoplasm
Grant awards (60)
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions$1,554,893
U01 · FY2025 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum Administrative Supplement$566,636
U01 · FY2025 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,508,560
U01 · FY2024 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,791,871
U01 · FY2023 · CA
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions$1,523,795
U01 · FY2023 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,791,664
U01 · FY2022 · CA
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions$1,600,160
U01 · FY2022 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$503,760
U01 · FY2022 · CA
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions$101,571
U01 · FY2022 · CA
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions$42,585
U01 · FY2022 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum - Supplement$34,980
U01 · FY2022 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,967,606
U01 · FY2021 · CA
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions$1,732,423
U01 · FY2021 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$503,760
U01 · FY2021 · CA
CISNET Lung Disparities Supplement$74,000
U01 · FY2021 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,963,075
U01 · FY2020 · CA
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions$1,802,154
U01 · FY2020 · CA
Comparative Modeling of Lung Cancer Prevention and Control Policies$1,584,503
U01 · FY2019 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,479,651
U01 · FY2019 · CA
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations$965,899
U01 · FY2019 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,740,652
U01 · FY2018 · CA
Comparative Modeling of Lung Cancer Prevention and Control Policies$1,644,588
U01 · FY2018 · CA
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations$1,019,043
U01 · FY2018 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$140,400
U01 · FY2018 · CA
Comparative Modeling of Lung Cancer Prevention and Control Policies$1,765,010
U01 · FY2017 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,760,379
U01 · FY2017 · CA
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations$1,036,582
U01 · FY2017 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$231,108
U01 · FY2017 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,785,514
U01 · FY2016 · CA
Comparative Modeling of Lung Cancer Prevention and Control Policies$1,680,258
U01 · FY2016 · CA
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations$1,066,817
U01 · FY2016 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,819,268
U01 · FY2015 · CA
Comparative Modeling of Lung Cancer Prevention and Control Policies$1,751,835
U01 · FY2015 · CA
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations$1,090,797
U01 · FY2015 · CA
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$590,778
U01 · FY2015 · CA
Comparative Modeling of Lung Cancer Control Policies$1,326,517
U01 · FY2014 · CA
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,314,797
U01 · FY2014 · CA
Modeling prostate cancer control: prevention, screening, treatment, followup care$1,068,320
U01 · FY2014 · CA
Comparative Modeling of Lung Cancer Control Policies$99,250
U01 · FY2014 · CA
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,725,720
U01 · FY2013 · CA
Comparative Modeling of Lung Cancer Control Policies$1,291,087
U01 · FY2013 · CA
Modeling prostate cancer control: prevention, screening, treatment, followup care$1,023,733
U01 · FY2013 · CA
Comparative Modeling of Lung Cancer Control Policies$1,377,303
U01 · FY2012 · CA
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,340,092
U01 · FY2012 · CA
Modeling prostate cancer control: prevention, screening, treatment, followup care$1,095,792
U01 · FY2012 · CA
Comparative Modeling of Lung Cancer Control Policies$109,989
U01 · FY2012 · CA
Comparative Modeling of Lung Cancer Control Policies$1,939,959
U01 · FY2011 · CA
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,352,685
U01 · FY2011 · CA
Modeling prostate cancer control: prevention, screening, treatment, followup care$1,065,485
U01 · FY2011 · CA
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,257,743
U01 · FY2010 · CA
Comparative Modeling of Lung Cancer Control Policies$1,252,774
U01 · FY2010 · CA
Modeling prostate cancer control: prevention, screening, treatment, followup care$1,002,475
U01 · FY2010 · CA
SURVEILLANCE OF LUNG CANCER TRENDS IN THE US WITH MISCAN$114,534
U01 · FY2009 · CA · contact PI
A trial-based MISCAN model for prostate cancer$105,209
U01 · FY2009 · CA · contact PI
A trial-based MISCAN model for prostate cancer$181,870
U01 · FY2008 · CA · contact PI
SURVEILLANCE OF LUNG CANCER TRENDS IN THE US WITH MISCAN$148,219
U01 · FY2008 · CA · contact PI
A trial-based MISCAN model for prostate cancer$180,067
U01 · FY2007 · CA · contact PI
SURVEILLANCE OF LUNG CANCER TRENDS IN THE US WITH MISCAN$147,685
U01 · FY2007 · CA · contact PI
A trial-based MISCAN model for prostate cancer$180,043
U01 · FY2006 · CA · contact PI
A trial-based MISCAN model for prostate cancer$182,507
U01 · FY2005 · CA